118 related articles for article (PubMed ID: 15470233)
1. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys.
Butenhoff JL; Kennedy GL; Hinderliter PM; Lieder PH; Jung R; Hansen KJ; Gorman GS; Noker PE; Thomford PJ
Toxicol Sci; 2004 Dec; 82(2):394-406. PubMed ID: 15470233
[TBL] [Abstract][Full Text] [Related]
2. Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).
Hinderliter PM; Han X; Kennedy GL; Butenhoff JL
Toxicology; 2006 Aug; 225(2-3):195-203. PubMed ID: 16857306
[TBL] [Abstract][Full Text] [Related]
3. Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats.
Hinderliter PM; Mylchreest E; Gannon SA; Butenhoff JL; Kennedy GL
Toxicology; 2005 Jul; 211(1-2):139-48. PubMed ID: 15863257
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans.
Olsen GW; Chang SC; Noker PE; Gorman GS; Ehresman DJ; Lieder PH; Butenhoff JL
Toxicology; 2009 Feb; 256(1-2):65-74. PubMed ID: 19059455
[TBL] [Abstract][Full Text] [Related]
5. Perfluorooctanoic acid: relationship between repeated inhalation exposures and plasma PFOA concentration in the rat.
Hinderliter PM; DeLorme MP; Kennedy GL
Toxicology; 2006 May; 222(1-2):80-5. PubMed ID: 16513238
[TBL] [Abstract][Full Text] [Related]
6. Modeling single and repeated dose pharmacokinetics of PFOA in mice.
Lou I; Wambaugh JF; Lau C; Hanson RG; Lindstrom AB; Strynar MJ; Zehr RD; Setzer RW; Barton HA
Toxicol Sci; 2009 Feb; 107(2):331-41. PubMed ID: 19005225
[TBL] [Abstract][Full Text] [Related]
7. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO).
Loveless SE; Finlay C; Everds NE; Frame SR; Gillies PJ; O'Connor JC; Powley CR; Kennedy GL
Toxicology; 2006 Mar; 220(2-3):203-17. PubMed ID: 16448737
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
9. Characterization of risk for general population exposure to perfluorooctanoate.
Butenhoff JL; Gaylor DW; Moore JA; Olsen GW; Rodricks J; Mandel JH; Zobel LR
Regul Toxicol Pharmacol; 2004 Jun; 39(3):363-80. PubMed ID: 15135214
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water.
Chang SC; Das K; Ehresman DJ; Ellefson ME; Gorman GS; Hart JA; Noker PE; Tan YM; Lieder PH; Lau C; Olsen GW; Butenhoff JL
Toxicol Sci; 2008 Jul; 104(1):40-53. PubMed ID: 18353799
[TBL] [Abstract][Full Text] [Related]
11. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months.
Butenhoff J; Costa G; Elcombe C; Farrar D; Hansen K; Iwai H; Jung R; Kennedy G; Lieder P; Olsen G; Thomford P
Toxicol Sci; 2002 Sep; 69(1):244-57. PubMed ID: 12215680
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
13. Absorption and excretion of 14C-perfluorooctanoic acid (PFOA) in Angus cattle (Bos taurus).
Lupton SJ; Huwe JK; Smith DJ; Dearfield KL; Johnston JJ
J Agric Food Chem; 2012 Feb; 60(4):1128-34. PubMed ID: 22224442
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the uptake and disposition of perfluorooctanoic acid in fathead minnows after oral dosing.
Lee JJ; Schultz IR
Environ Sci Technol; 2010 Jan; 44(1):491-6. PubMed ID: 19961202
[TBL] [Abstract][Full Text] [Related]
15. Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance.
York RG; Kennedy GL; Olsen GW; Butenhoff JL
Toxicology; 2010 Apr; 271(1-2):64-72. PubMed ID: 20223269
[TBL] [Abstract][Full Text] [Related]
16. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
17. Biochemical responses and accumulation properties of long-chain perfluorinated compounds (PFOS/PFDA/PFOA) in juvenile chickens (Gallus gallus).
Yeung LW; Loi EI; Wong VY; Guruge KS; Yamanaka N; Tanimura N; Hasegawa J; Yamashita N; Miyazaki S; Lam PK
Arch Environ Contam Toxicol; 2009 Aug; 57(2):377-86. PubMed ID: 19130113
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
